VitalFlo

Overview

Raised to Date: Raised: $242,228

Deal Terms

Investment Momentum

Company Profile

Deal Summary

Financials

Total Commitments ($USD)

Platform

Wefunder

Start Date

11/01/2022

Close Date

04/30/2023

Min. Goal

$275,000

Max. Goal

$1,000,000

Min. Investment

$250

Security Type

SAFE

Series

Seed

SEC Filing Type

RegCF    

Valuation Cap

$7,000,000

Discount

20%

Venture Capital Investors:

Techstars

Geekdom Fund

Elevate Capital

Geekdom Fund

Elevate Capital

Purpose Built

Rolling Commitments ($USD)

Status

Active

Reporting Date

03/27/2023

Days Remaining

34

% of Min. Goal

88%

% of Max. Goal

24%

Likelihood of Max

Avg. Daily Raise

$1,659

# of Investors

109

Momentum

Create a free account today to gain access to KingsCrowd analytics.

Logos provided by Clearbit

VitalFlo

Year Founded

2017

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B

Margin

Medium

Capital Intensity

Low

Location

Raleigh, North Carolina

Business Type

Growth

Company Website

VitalFlo, with a valuation of $7 million, is raising funds on Wefunder. The company has developed a device and software that help doctors measure, monitor, and predict patients’ lung health. The VitalFlo device unlocks spirometry or pulmonary function testing for patients and their primary care doctors. The business launched with a 90-hospital Health System group in May 2022 and has reported a 2.7 times subscription growth quarter-over-quarter. Luke Marshall and Andy Taylor founded VitalFlo in April 2017. The current crowdfunding campaign has a minimum target of $275,000 and a maximum target of $1 million. The campaign proceeds will be used for R&D, sales and marketing, and general and administrative expenses.

Summary Profit and Loss Statement

	Most Recent Year	Prior Year
Revenue	$72,690	$42,877
COGS	$43,118	$1,937
Tax	$200	$204
Net Income	$-741,679	$-159,223

Summary Balance Sheet

	Most Recent Year	Prior Year
Cash	$712,911	$141,748
Accounts Receivable	$16,543	$11,619
Total Assets	$877,926	$267,729
Short-Term Debt	$39,277	$75,823
Long-Term Debt	$0	$725,000
Total Liabilities	$39,277	$800,823

Financials as of: 11/01/2022

Create a free account today to gain access to KingsCrowd analytics.

One in 13 Americans suffer from asthma. And asthma is just one of the many reasons someone might have to undergo lung function testing. These tests typically involve a device called a peak flow meter (aka spirometer), which measures the airflow that comes out of the lungs. It is the most common way to track lung function for those with asthma, allergies, chronic obstructive pulmonary disease, and other conditions that affect breathing. Normally, the test has to be done in a doctor’s office, usually a specialist’s. And because of patient backlogs, waiting weeks or months to have a test done is not unusual. 

VitalFlo was founded to make lung function testing as easy as taking your blood pressure. Founder and CEO Luke Marshall saw how much inconvenience and wasted time patients were going through. That’s why he and the VitalFlo team built out software to make lung function testing available at home or in primary care offices.

Upgrade to view full report